GlassScriptPhysician profile
David Duane Beck
NPI 1871539627
$527.39
in general payments reported to CMS, 2019-2025
8 companies · $265 in 2025
The $265 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $47.53 · 2022: $82.43 · 2023: $102 · 2024: $30.77 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $223.16 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| W. L. Gore & Associates, INC. | $82.43 | 2022 | |
| Ethicon US, LLC | $65.36 | 2021-2025 | Stratafix |
| Integra Lifesciences Corporation | $46.04 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Dilon Technologies, INC. | $29.76 | 2023 | Hemoblast Bellows |
| Baxter Healthcare | $28.41 | 2025 | Tisseel |
| Solventum Corporation | $26.35 | 2025 | Abthera, V.A.C.Ulta, Activ.A.C. |
| Abbvie INC. | $25.88 | 2023 | Strattice Reconstructive Tissue Matrix Bps |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Beck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.